Vitamin K2 Market Worth $1.16 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners

The global vitamin K2 market is growing at a CAGR of 29.7% from 2022 to 2030.Pune, India, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Vitamin K2, also known as menaquinone, is a part of vitamin K family. It plays an important role in keeping bones and heart healthy. MK-4 and MK-7 are the main isomers that are found to be most beneficial. Adequate intake of vitamin K2 is associated with lower risk of vascular damage because it activates matrix GLA protein (MGP) and activates osteocalcin. MGP inhibits blood

Related Keywords

Tokyo ,Japan ,India ,United States ,Pune ,Maharashtra ,America ,Japanese ,Asia Pacific ,Ankit Mathur ,Health Solutions Inc ,Lonza Group ,Balchem Corporation ,European Food Safety Authority ,Application Pharmaceuticals ,International Flavors Fragrances Inc ,Seebio Biotech Shanghai Co Ltd ,Adare Pharma Solutions ,Glanbia Plc ,Balchem Corp ,Anderson Global Group ,Regional Share ,Growth Opportunity Analysis Report Coverage ,Combination Drugs ,Dosage Forms ,North America ,Middle East ,Central America ,Competitive Landscape ,International Flavors ,Fragrances Inc ,Seebio Biotech ,Kappa Bioscience ,Raj Oil Mills ,Adare Biome ,Standards Would Lead ,Future Trends ,Segmental Overview ,Insight Partners ,Medical Device ,Vitamin K2 ,Market Presence ,